Search research articles
Contact Us
Filters
Showing results (171-180 of 174) with videos related to
Page
of 18
Sort By:
You have reached the last page of results.
This site can display upto 174 results.
Lancet (London, England)
|
August 13, 2021
Protection by vaccination of children against typhoid fever with a Vi-tetanus toxoid conjugate vaccine in urban Bangladesh: a cluster-randomised trial
Firdausi Qadri, Farhana Khanam, Xinxue Liu, et al.
The Journal of Infectious Diseases
|
July 16, 2024
Pneumococcal Carriage and Disease in Adults in England, 2011-2019: The Importance of Adults as a Reservoir for Pneumococcus in Communities
Dima El Safadi, Lisa Hitchins, Ashleigh Howard, et al.
Lancet (London, England)
|
November 22, 2020
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
Maheshi N Ramasamy, Angela M Minassian, Katie J Ewer, et al.
Lancet (London, England)
|
December 11, 2020
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Merryn Voysey, Sue Ann Costa Clemens, Shabir A Madhi, et al.
Page
of 18
Search research articles
Search
Showing results (171-180 of 174) with videos related to
Sort By:
Page
of 18
You have reached the last page of results.
This site can display upto 174 results.
Lancet (London, England)
|
August 13, 2021
Protection by vaccination of children against typhoid fever with a Vi-tetanus toxoid conjugate vaccine in urban Bangladesh: a cluster-randomised trial
Firdausi Qadri, Farhana Khanam, Xinxue Liu, et al.
The Journal of Infectious Diseases
|
July 16, 2024
Pneumococcal Carriage and Disease in Adults in England, 2011-2019: The Importance of Adults as a Reservoir for Pneumococcus in Communities
Dima El Safadi, Lisa Hitchins, Ashleigh Howard, et al.
Lancet (London, England)
|
November 22, 2020
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
Maheshi N Ramasamy, Angela M Minassian, Katie J Ewer, et al.
Lancet (London, England)
|
December 11, 2020
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Merryn Voysey, Sue Ann Costa Clemens, Shabir A Madhi, et al.
Page
of 18